ABBOTT IRELAND DIAGNOSTICS DIVISION ALINITY I CMV IGG REAGENT KIT; ENZYME LINKED IMMUNOABSORBENT ASSAY, CYTOMEGALOVIRUS
|
Back to Search Results |
|
Catalog Number 07P42-32 |
Device Problem
False Negative Result (1225)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 01/07/2024 |
Event Type
malfunction
|
Event Description
|
The customer observed false nonreactive alinity i cmv igg results for one patient.The sample was repeated three more times and a reactive result was obtained.The following data was provided: sid (b)(6): first run (1:10 dilution) = <11 au/ml, second run (undiluted) = >250 au/ml, third run (1:10 dilution) = <11 au/ml, fourth run (1:10 dilution) = 600 au/ml.Per the alinity i cmv igg package insert, interpretation of results section: specimens with concentration values = 6.0 au/ml are considered reactive and < 6.0 au/ml are considered nonreactive.There was no impact to patient management reported.
|
|
Manufacturer Narrative
|
This report is being filed on an international product, alinity i cmv igg, list number 07p42-32, that has a similar product distributed in the us, list number 7p42-24/-33.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
|
|
Manufacturer Narrative
|
The complaint investigation for false nonreactive alinity i cmv igg results included a review of data and information provided by the customer, search for similar complaints, ticket trending review, device history record review, and labeling review.Additionally, in-house testing of retained reagent kit was also completed.Return testing was not completed as returns were not available.The data and information provided by the customer were reviewed and support the complaint issue.A ticket search by lot indicates that the reagent lot performs as expected for this product.A review of the complaint trending report did not identify any trends for the issue for the product.A review of the device history record did not identify any non-conformances or deviations with the lot number 51601fn00 and the complaint issue.A review of labeling was performed and found to sufficiently address the customer's issue.Furthermore, clinical sensitivity testing was performed using an in-house retained reagent kit of the complaint lot.All specifications were met which indicates the lot is performing as expected.Based on our investigation, no systemic issue or deficiency with the alinity i cmv igg reagent for lot 51601fn00 was identified.
|
|
Event Description
|
The customer observed false nonreactive alinity i cmv igg results for one patient.The sample was repeated three more times and a reactive result was obtained.The following data was provided: sid (b)(6): first run (1:10 dilution) = <11 au/ml second run (undiluted) = >250 au/ml third run (1:10 dilution) = <11 au/ml fourth run (1:10 dilution) = 600 au/ml per the alinity i cmv igg package insert, interpretation of results section: specimens with concentration values = 6.0 au/ml are considered reactive and < 6.0 au/ml are considered nonreactive.There was no impact to patient management reported.
|
|
Search Alerts/Recalls
|
|
|